Biomimetic nanosponges suppress in vivo lethality induced by the whole secreted proteins of pathogenic bacteria

Summary

This preclinical study examines whether red-blood-cell-membrane nanosponges can neutralize the complex mixture of virulence proteins secreted by methicillin-resistant Staphylococcus aureus and whether in vitro neutralization predicts animal benefit. Whole secreted proteins were collected from the bacterium, preserving a multifactorial virulence profile while avoiding the changing biology of live infection. The investigators first quantified how well the coated polymeric particles blocked hemolytic activity in vitro. In mice challenged with a lethal dose of the secreted mixture, nanosponge treatment neutralized hemolysis and significantly improved survival. Under a sublethal challenge, treatment also reduced lung injury and suppressed activation of nuclear factor kappa B in the spleen. The principal finding is a direct link between broad toxin sequestration measured in vitro and protection from a complex bacterial secretome in vivo. Rather than targeting one named toxin, the membrane decoy absorbs multiple harmful factors through their shared tendency to attack host cells. Its significance is an antivirulence approach relevant to severe MRSA syndromes such as bacteremia and sepsis. The abstract does not model live infection, compare antibiotics or antitoxins, identify captured proteins, or establish dosing, pharmacokinetics, and human safety.